A Need for Automation: Clinics must now focus on automating insurance verification and streamlining patient onboarding to handle the increased caseload efficiently
Nitric oxide scavenging by curcuminoids
Doi:10.1016/S0140-6736(21)00213-0 Wadden TA, Bailey TS, Billings LK, et al
KFFs analysis of newly released Medicare Part D spending data from CMS shows that total gross Medicare spending on the three newest versions of these diabetes medications that have also been recently approved for weight loss Ozempic, Rybelsus, and Mounjaro has skyrocketed in recent years, rising from $57 million in 2018 to $5.7 billion in 2022 (Figure 1)
For more information on 503Bs, the FDA offers a list of all the registered 503B compounding pharmacies in the United States
( NEJM, JAMA, Obesity, Lancet, and others where there is an eye toward the validity of the study.) And, are the results statistically significant